Chemotherapy of human African trypanosomiasis: current and future prospects

Research output: Contribution to journalReview articlepeer-review

294 Citations (Scopus)


Three of the four currently approved drugs for the treatment of African trypanosomiasis (sleeping sickness) were developed over 50 years ago. All of the current therapies are unsatisfactory for various reasons, including unacceptable toxicity, poor efficacy, undesirable route of administration, and drug resistance. The possible modes of action of these drugs are briefly reviewed, as are the possible mechanisms of resistance. The intermediate and long-term prospects for the development of safer, effective drugs are discussed.

Original languageEnglish
Pages (from-to)488-494
Number of pages7
JournalTrends in Parasitology
Issue number11
Publication statusPublished - 1 Nov 2003

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases


Dive into the research topics of 'Chemotherapy of human African trypanosomiasis: current and future prospects'. Together they form a unique fingerprint.

Cite this